Does Rallies show Form 4 insider transactions for PHGE?

Yes. Rallies tracks PHGE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PHGE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PHGE. It does not provide personalized investment advice.

PHGE (BiomX Inc.) Stock Analysis - Insider Trades

BiomX Inc. (PHGE) is a publicly traded Healthcare sector company. As of May 21, 2026, PHGE trades at $0.61 with a market cap of $4.66M and a P/E ratio of 0.03. PHGE moved +56.95% today. Year to date, PHGE is -73.59%; over the trailing twelve months it is -94.25%. Its 52-week range spans $0.36 to $22.06. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces PHGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PHGE stock inside the company?

Recent PHGE insider activity includes Yeganeh Reuven sold 530.00K, Yeganeh Reuven sold 450.00K, Yeganeh Reuven sold 370.00K, Yeganeh Reuven sold 300.00K, and OrbiMed Israel BioFund GP Limited Partnership sold 24.34K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PHGE Key Metrics

Key financial metrics for PHGE
Metric	Value
Price	$0.61
Market Cap	$4.66M
P/E Ratio	0.03
EPS	$22.19
Dividend Yield	0.00%
52-Week High	$22.06
52-Week Low	$0.36
Volume	3.87M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-36.20M
Gross Margin	0.00%

Recent PHGE Insider Trades

Yeganeh Reuven sold 530.00K (~$2.65M) on Mar 17, 2026.
Yeganeh Reuven sold 450.00K (~$2.25M) on Mar 16, 2026.
Yeganeh Reuven sold 370.00K (~$1.85M) on Mar 13, 2026.
Yeganeh Reuven sold 300.00K (~$1.50M) on Mar 12, 2026.
OrbiMed Israel BioFund GP Limited Partnership sold 24.34K (~$9.28K) on May 15, 2024.

Latest PHGE News

BiomX’s Zorronet Launches Mobile AI App Tapping $44B Command-and-Control Market — May 6, 2026
BiomX Secures Framework Deal After 98% Success in NIS 800K Rail Pilot — Apr 16, 2026
BiomX to Acquire DFSL with $12 Warrants, Adds 99%-Accurate LADAR — Apr 13, 2026
BiomX Acquires Zorronet to Target $81 Billion Defense C2 and Video Analytics Market — Apr 10, 2026
BiomX Plans $45M Acquisition of Laser-Radar Counter-Drone Developer with 99% Accuracy — Mar 31, 2026

PHGE Analyst Consensus

1 analysts cover PHGE: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Common questions about PHGE

Who is trading PHGE stock inside the company?: Recent PHGE insider activity includes Yeganeh Reuven sold 530.00K, Yeganeh Reuven sold 450.00K, Yeganeh Reuven sold 370.00K, Yeganeh Reuven sold 300.00K, and OrbiMed Israel BioFund GP Limited Partnership sold 24.34K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PHGE?: Yes. Rallies tracks PHGE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PHGE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PHGE. It does not provide personalized investment advice.